• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Molecular machinery that makes potent antibiotic revealed after decades of research

Bioengineer by Bioengineer
January 17, 2019
in Immunology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Discovery by Rutgers and other scientists could lead to new antibiotics and anticancer drugs

IMAGE

Credit: Dmitry Ghilarov

Scientists at Rutgers and universities in Russia, Poland and England have solved a nearly 30-year mystery – how the molecular machinery works in an enzyme that makes a potent antibiotic.

The findings, which appear in the journal Molecular Cell, provide the tools to design new antibiotics, anticancer drugs and other therapeutics.

The potent natural antibiotic, microcin B17, kills harmful E. coli bacteria. Microbial resistance to antibiotics- due to their overuse and misuse – is one of the biggest threats facing humanity, and there’s an urgent need to find new drugs. Natural antibiotics that evolved over eons represent an attractive option to overcome resistance.

The scientists studied a molecular machine: an enzyme (protein) called McbBCD. The enzyme makes microcin B17 from a smaller protein known as a peptide. Scientists have known about microcin B17 and its unusual chemical structure for decades, but they did not understand the molecular machinery that makes it until now.

The scientists found that the enzyme triggers two chemical reactions that produce several chemical “cycles” required for antibacterial activity, according to senior author Konstantin Severinov, a principal investigator at the Waksman Institute of Microbiology and professor of molecular biology and biochemistry at Rutgers University-New Brunswick.

“Our research allows rational design of new peptide compounds that could become treatments ranging from antimicrobials to anticancer drugs,” Severinov said. “There may be a trove of new antibiotics that could be made from peptides, using enzyme machines like McbBCD as a production tool.”

The international team included scientists at the Skolkovo Institute of Science and Technology in Russia; Russian Academy of Sciences in Russia; Jagiellonian University in Poland; John Innes Centre in England; and Lomonosov Moscow State University in Russia.

###

Media Contact
Todd Bates
[email protected]
848-932-0550

Original Source

https://news.rutgers.edu/molecular-machinery-makes-potent-antibiotic-revealed-after-decades-research/20190114#.XDzPUVxKi70

Related Journal Article

http://dx.doi.org/10.1016/j.molcel.2018.11.032

Tags: BiochemistryCell BiologyInfectious/Emerging DiseasesMedicine/HealthMicrobiologyMolecular BiologyPharmaceutical ChemistryPharmaceutical SciencePublic Health
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Meet the Finalists: 2025 Blavatnik National Awards for Young Scientists Revealed

AI-Enhanced Satellite Technology Tracks Migration Patterns of Wildebeest

Future Ocean Warming Threatens Prochlorococcus Biomass

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.